Evidence map›Paper›PMID 31832123›Full record

ArticleBiomicrofluidics2019

A 3D-printed microfluidic-enabled hollow microneedle architecture for transdermal drug delivery.

Christopher Yeung, Shawnus Chen, Brian King, Haisong Lin, Kimber King, Farooq Akhtar, Gustavo Diaz, Bo Wang, Jixiang Zhu, Wujin Sun and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Biomicrofluidics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
8.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 210 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Microfluidics-Based Microcarriers for Live-Cell Delivery.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  10. 3D printed microneedles: revamping transdermal drug delivery systems.Drug delivery and translational research · 2025
    Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Christopher YeungORCID 0000-0002-8964-1044
Shawnus Chen
Haisong LinInterconnected & Integrated Bioelectronics Lab (I2BL), Department of Electrical and Computer Engineering, University of California, Los Angeles, California 90095, USA.ORCID 0000-0002-5684-6385
Kimber KingInterconnected & Integrated Bioelectronics Lab (I2BL), Department of Electrical and Computer Engineering, University of California, Los Angeles, California 90095, USA.
Farooq AkhtarInterconnected & Integrated Bioelectronics Lab (I2BL), Department of Electrical and Computer Engineering, University of California, Los Angeles, California 90095, USA.
Gustavo DiazInterconnected & Integrated Bioelectronics Lab (I2BL), Department of Electrical and Computer Engineering, University of California, Los Angeles, California 90095, USA.
Bo WangInterconnected & Integrated Bioelectronics Lab (I2BL), Department of Electrical and Computer Engineering, University of California, Los Angeles, California 90095, USA.ORCID 0000-0002-3986-3415
Jixiang Zhu
Wujin Sun
Ali Khademhosseini
Sam Emaminejad
BioElectronics (United States) · USCalifornia NanoSystems Institute · USUniversity of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Embedding microfluidic architectures with microneedles enables fluid management capabilities that present new degrees of freedom for transdermal drug delivery. To this end, fabrication schemes that can simultaneously create and integrate complex millimeter/centimeter-long microfluidic structures and micrometer-scale microneedle features are necessary. Accordingly, three-dimensional (3D) printing techniques are suitable candidates because they allow the rapid realization of customizable yet intricate microfluidic and microneedle features. However, previously reported 3D-printing approaches utilized costly instrumentation that lacked the desired versatility to print both features in a single step and the throughput to render components within distinct length-scales. Here, for the first time in literature, we devise a fabrication scheme to create hollow microneedles interfaced with microfluidic structures in a single step. Our method utilizes stereolithography 3D-printing and pushes its boundaries (achieving print resolutions below the full width half maximum laser spot size resolution) to create complex architectures with lower cost and higher print speed and throughput than previously reported methods. To demonstrate a potential application, a microfluidic-enabled microneedle architecture was printed to render hydrodynamic mixing and transdermal drug delivery within a single device. The presented architectures can be adopted in future biomedical devices to facilitate new modes of operations for transdermal drug delivery applications such as combinational therapy for preclinical testing of biologic treatments.

Identifiers

PMID31832123
PMCPMC6906119
OpenAlexW2994992793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.